Description
A bioactive sphingolipid; levels increase time-dependently in a nutrient deprivation-induced necroptosis model in MEF cells; reduced levels in obese patients after chronic exercise correlate with weight and fat loss; higher levels in Parkinson’s disease patients correlate with memory deficits,
Formal name: N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-tetradecanamide
Synonyms: C14 Ceramide|Cer(d18:1/14:0)|Ceramide (d18:1/14:0)
Molecular weight: 509.9
CAS: 34227-72-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cell Biology|Cell Death|Necroptosis||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity||Research Area|Lipid Biochemistry|Sphingolipids||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease